<DOC>
	<DOCNO>NCT02570217</DOCNO>
	<brief_summary>Preterm infant range 29+0 36+6 weeks+days randomly assign one follow treatment non invasive respiratory support develop mild moderate Respiratory Distress Syndrome within 72 hrs birth : 1 ) NCPAP set 4-6 cmH2O 2 ) HHHFNC provide flow 4-6 l/min . The aim study assess efficacy safety relative `` new '' form respiratory support ( HHHFNC ) versus common one ( NCPAP ) .</brief_summary>
	<brief_title>HHHFNC ( Heated Humidified High-Flow Nasal Cannula ) Versus NCPAP Respiratory Distress Syndrome Prematurity</brief_title>
	<detailed_description>Preterm infant eligible study present mild moderate Respiratory Distress Syndrome ( RDS ) define follow criterion : need FiO2 ( Fraction Inspired Oxygen ) ≥0.30 keep target SpO2 ( Periferal Oxygen Saturation ) beetween 88-93 % and/or Silverman score ≥5 . To confirm diagnosis Chest XR perform routinarily ward start respiratory support . They randomly assign one treatment group cite `` brief summary '' mean close envelops . A block randomization applided blok size 4 . The randomization stratify per group accoring gestational age : 29+0 32+6 ; 33+0 34+6 ; 35+0 36+6 weeks+days . Once treatment start , group NCPAP possibility switch mode `` Bi-PAP '' : 4 episode apnoea per hour 2 episode require positive pressure ventilation deem clinician increase work breathing assesed Silverman score . For group , FiO2 requirement persistently high 0.35-0.40 per target SpO2 86-93 % and/or dyspnoea define Silverman score &gt; 6 start respiratory support , newborn receive Surfactant `` INSURE '' technique , involve endotracheal intubation direct laryngoscopic vision , endotracheal administration surfactant ( Curosurf , Chiesi Pharmaceutics , Parma , Italy ) 200 mg/kg finally extubation . After administration surfactant , FiO2 requirement persistently &gt; 0.4 keep SpO2 86-93 % severe apnea episode present ( apnea episode &gt; 4/hr &gt; 2/hr require positive pressure ventilation ) blood gas ( capillary venous ) PaCO2 &gt; 70 mmHg pH &lt; 7.20 , newborn intubate mechanically ventilate . For newborn enrol study , capillary venous blood gas check every 6-12 hour , cerebral cardiac ultrasound screening perform within 24 hr . Further control follow routine ward . Weaning start decrease HHHFNC flow 1 lpm nCPAP pressure 1 cmH2O pressure infant present FIO2 &lt; 0.30 target SpO2 minimal sign respiratory effort . The respiratory support discontinue flow ≤ 2 lpm pressure ≤ 2 cmH2O .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Hyaline Membrane Disease</mesh_term>
	<criteria>Inborn Parental Consent No parental consent Major congenital malformation Severe intra ventricular hemorrage diagnose early birth</criteria>
	<gender>All</gender>
	<minimum_age>29 Weeks</minimum_age>
	<maximum_age>36 Weeks</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>NCPAP , High Flow Nasal Cannula , pretem infant , NICU</keyword>
</DOC>